Chong Kun Dang rallies on $1.3 bn deal with Novartis

Chong Kun Dang Pharmaceutical Corp.'s shares zoomed more than 25% on Monday on news that the South Korean medicine developer has signed its biggest-...

Novartis $391 mn deal powers Samsung Biologics backlogs to record high

Samsung Biologics Co., the world’s top contract manufacturing organization by capacity, inked a $391 million contract from Novartis, nearly fi...

S.Korea's Alteogen signs $145 million tech export deal with Swiss company

South Korea's bio company Alteogen Inc. on Friday said it signed its fourth technology export contract since its 2018 development of the human recom...

Samsung Biologics signs $81 mn CMO deal with Novartis

South Korea’s Samsung Biologics Co. has inked an $81 million contract manufacturing deal with Novartis, the world’s fifth-largest pharma...

Korean brokerage firm to buy Novartis campus in Paris for $454 mn: report

Korea Investment & Securities Co. Ltd. is set to buy an office building of Swiss pharmaceutical company Novartis under construction in Paris for 5...